Alisol B

CAS No. 18649-93-9

Alisol B( —— )

Catalog No. M20406 CAS No. 18649-93-9

Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 188 In Stock
5MG 187 In Stock
10MG 278 In Stock
25MG 472 In Stock
50MG 644 In Stock
100MG 913 In Stock
200MG 1228 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Alisol B
  • Note
    Research use only, not for human use.
  • Brief Description
    Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions.
  • Description
    Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol B also inhibited RANKL-induced expression of NFATc1 and c-Fos which are key transcription factors for osteoclastogenesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    RANKL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18649-93-9
  • Formula Weight
    472.7
  • Molecular Formula
    C30H48O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:95 mg/mL (200.97 mM)
  • SMILES
    [H][C@@]1(OC1(C)C)[C@@H](O)C[C@@H](C)C1=C2C[C@H](O)[C@@]3([H])[C@@]4(C)CCC(=O)C(C)(C)[C@]4([H])CC[C@]3(C)[C@@]2(C)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lee J W Kobayashi Y Nakamichi Y et al. Alisol-B a novel phyto-steroid suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice[J]. Biochemical Pharmacology 2010 80(3):352-361.
molnova catalog
related products
  • Mukanadin C

    Mukanadin C is a marine derived natural products found in Stylissa carteri.

  • Bexmarilimab

    Bexmarilimab (FP-1305) is a highly potent, humanized anti-CLEVER-1 IgG4 antibody with an IC50 value of 4.51 nM, promoting immune conversion of tumor-associated macrophage phenotype M2 to M1, and can be used to study cancer.

  • EC23

    EC23 is a stable synthetic retinoid analogue. It is also induces neuronal differentiation.